Sign Up to like & get
recommendations!
1
Published in 2022 at "Psychiatry Research"
DOI: 10.1016/j.psychres.2022.114486
Abstract: BACKGROUND Several lines of evidence suggest that glutamatergic neurotransmission via the N-methyl-D-aspartate (NMDA) receptor plays a role in certain behavioral manifestations common to Post-Traumatic Stress Disorder (PTSD). Ifenprodil tartrate is a neuroprotective agent that binds…
read more here.
Keywords:
post traumatic;
traumatic stress;
ifenprodil;
stress disorder ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.0c01912
Abstract: Ifenprodil (1) is a potent GluN2B-selective N-methyl-d-aspartate (NMDA) receptor antagonist that is used as a cerebral vasodilator and has been examined in clinical trials for the treatment of drug addiction, idiopathic pulmonary fibrosis, and COVID-19.…
read more here.
Keywords:
configuration;
ifenprodil;
ifenprodil stereoisomers;
glun2b nmda ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15080960
Abstract: GluN2B-enriched N-methyl-D-aspartate receptors (NMDARs) are implicated in several neurodegenerative and psychiatric diseases, such as Alzheimer’s disease. No clinically valid GluN1/2B therapeutic exists due to a lack of selective GluN2B imaging tools, and the state-of-the-art [3H]ifenprodil…
read more here.
Keywords:
development validation;
ifenprodil;
nb1 preclinical;
preclinical assessment ... See more keywords